Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shevde

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Biology|August 18, 2006
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancersSungtae Kim, Miwa Yamazaki, Lee A Zella, et al.
Anesthesia and Analgesia|April 1, 1997
Acupressure treatment for prevention of postoperative nausea and vomitingC F Fan, E Tanhui, S Joshi, et al.
Molecular Endocrinology (Baltimore, Md.)|April 1, 2006
The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cellsMark B Meyer, Makoto Watanuki, Sungtae Kim, et al.
Journal of Clinical Anesthesia|May 20, 2000
Gender is an essential determinant of blood transfusion in patients undergoing coronary artery bypass graft procedureK Shevde, M Pagala, A Kashikar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 19, 2007
1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start siteJackie A Fretz, Lee A Zella, Sungtae Kim, et al.
Molecular Endocrinology (Baltimore, Md.)|April 15, 2006
1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcriptionJackie A Fretz, Lee A Zella, Sungtae Kim, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|October 30, 2001
Enhanced activity of osteoblast differentiation factor (PEBP2alphaA2/CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosisN K Shevde, A C Bendixen, M Maruyama, et al.
Molecular Endocrinology (Baltimore, Md.)|December 8, 2007
Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphataseJackie A Fretz, Nirupama K Shevde, Sujay Singh, et al.
Endocrinology|March 29, 2008
Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivoLee A Zella, Nirupama K Shevde, Bruce W Hollis, et al.
The Journal of Biological Chemistry|June 11, 2003
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblastsHironori Yamamoto, Nirupama K Shevde, Anjali Warrier, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Biology|August 18, 2006
Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancersSungtae Kim, Miwa Yamazaki, Lee A Zella, et al.
Anesthesia and Analgesia|April 1, 1997
Acupressure treatment for prevention of postoperative nausea and vomitingC F Fan, E Tanhui, S Joshi, et al.
Molecular Endocrinology (Baltimore, Md.)|April 1, 2006
The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cellsMark B Meyer, Makoto Watanuki, Sungtae Kim, et al.
Journal of Clinical Anesthesia|May 20, 2000
Gender is an essential determinant of blood transfusion in patients undergoing coronary artery bypass graft procedureK Shevde, M Pagala, A Kashikar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 19, 2007
1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start siteJackie A Fretz, Lee A Zella, Sungtae Kim, et al.
Molecular Endocrinology (Baltimore, Md.)|April 15, 2006
1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcriptionJackie A Fretz, Lee A Zella, Sungtae Kim, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|October 30, 2001
Enhanced activity of osteoblast differentiation factor (PEBP2alphaA2/CBFa1) in affected sutural osteoblasts from patients with nonsyndromic craniosynostosisN K Shevde, A C Bendixen, M Maruyama, et al.
Molecular Endocrinology (Baltimore, Md.)|December 8, 2007
Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphataseJackie A Fretz, Nirupama K Shevde, Sujay Singh, et al.
Endocrinology|March 29, 2008
Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivoLee A Zella, Nirupama K Shevde, Bruce W Hollis, et al.
The Journal of Biological Chemistry|June 11, 2003
2-Methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 potently stimulates gene-specific DNA binding of the vitamin D receptor in osteoblastsHironori Yamamoto, Nirupama K Shevde, Anjali Warrier, et al.
Pageof 6